Dyadic International Inc (DYAI)
1.95
+0.25
(+14.71%)
USD |
NASDAQ |
May 24, 16:00
2.00
+0.05
(+2.56%)
After-Hours: 20:00
Dyadic International Shareholders Equity (Quarterly): 4.516M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.516M |
| December 31, 2023 | 5.879M |
| September 30, 2023 | 7.652M |
| June 30, 2023 | 8.986M |
| March 31, 2023 | 10.80M |
| December 31, 2022 | 11.09M |
| September 30, 2022 | 12.61M |
| June 30, 2022 | 13.56M |
| March 31, 2022 | 16.39M |
| December 31, 2021 | 18.39M |
| September 30, 2021 | 21.90M |
| June 30, 2021 | 23.16M |
| March 31, 2021 | 25.69M |
| December 31, 2020 | 28.45M |
| September 30, 2020 | 29.99M |
| June 30, 2020 | 32.09M |
| March 31, 2020 | 34.25M |
| December 31, 2019 | 35.86M |
| September 30, 2019 | 37.24M |
| June 30, 2019 | 38.62M |
| March 31, 2019 | 40.59M |
| Date | Value |
|---|---|
| December 31, 2018 | 42.45M |
| September 30, 2018 | 42.91M |
| June 30, 2018 | 46.30M |
| March 31, 2018 | 47.83M |
| December 31, 2017 | 49.98M |
| September 30, 2017 | 51.79M |
| June 30, 2017 | 53.23M |
| March 31, 2017 | 54.44M |
| December 31, 2016 | 57.69M |
| September 30, 2016 | 63.25M |
| June 30, 2016 | 68.03M |
| March 31, 2016 | 69.21M |
| December 31, 2015 | 73.79M |
| September 30, 2015 | -0.6302M |
| December 31, 2014 | -2.265M |
| March 31, 2014 | 1.172M |
| December 31, 2013 | 2.568M |
| September 30, 2013 | 2.982M |
| June 30, 2013 | 4.405M |
| March 31, 2013 | 0.7612M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.516M
Minimum
Mar 2024
38.62M
Maximum
Jun 2019
20.86M
Average
20.15M
Median
Shareholders Equity (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 4.826M |
| Perspective Therapeutics Inc | 229.89M |
| Protalix BioTherapeutics Inc | 29.79M |
| Electromed Inc | 42.54M |
| Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.68M |
| Total Liabilities (Quarterly) | 8.166M |
| Debt to Equity Ratio | 1.290 |
| Current Ratio | 5.544 |
| Net Debt Paydown Yield | -2.39% |